Steven Cohen’s Sagimet Biosciences SGMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$352K Buy
+35,629
New +$327K ﹤0.01% 3273
2026
Q2
– Sell
-187,564
Closed -$980K – 4519
2026
Q1
$980K Buy
187,564
+11,734
+7% +$65.4K ﹤0.01% 2770
2025
Q4
$1.04M Buy
+175,830
New +$1.26M ﹤0.01% 2854
2025
Q2
– Sell
-1,755,143
Closed -$5.72M – 2562
2025
Q1
$5.72M Sell
1,755,143
-561,429
-24% -$2.35M 0.01% 876
2024
Q4
$10.4M Sell
2,316,572
-77,356
-3% -$392K 0.02% 684
2024
Q3
$6.63M Buy
2,393,928
+27,838
+1% +$85.8K 0.02% 789
2024
Q2
$8.09M Sell
2,366,090
-300,694
-11% -$1.38M 0.02% 693
2024
Q1
$14.5M Buy
+2,666,784
New +$19.2M 0.04% 576

Other funds holding SGMT

Steven Cohen's SGMT Position: Q3 2026 in Review

Steven Cohen opened a new position in Sagimet Biosciences (SGMT) in Q3 2026: 35,629 shares worth $352K. The stake represents ﹤0.01% of the portfolio and ranks #3273 among its holdings. This is a return to the name: Steven Cohen previously reported a position in SGMT as recently as Q1 2026.

Steven Cohen first reported a position in SGMT in Q1 2024 and has held it in 8 quarters since. The position peaked at $14.5M in Q1 2024. 153 funds tracked by Wall St. Rank hold SGMT as of Q3 2026.

  • Steven Cohen held 35,629 shares of Sagimet Biosciences worth $352K as of Q3 2026.
  • Sagimet Biosciences was a new Steven Cohen position in Q3 2026.
  • Sagimet Biosciences made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3273 holding.
  • Steven Cohen first reported a position in Sagimet Biosciences in Q1 2024 and has held it in 8 quarters since.
  • Steven Cohen's Sagimet Biosciences position peaked at $14.5M in Q1 2024.
  • 153 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.